ArticleFrontline gastroenterology2023

Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II).

Richard J Aspinall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.